| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/19/2000 | EP0972200A1 Screening and treatment using complement regulator or receptor proteins |
| 01/19/2000 | EP0972069A1 Production of functional proteins: balance of shear stress and gravity |
| 01/19/2000 | EP0972063A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972050A1 Csk homologons kinaze (chk) for detecting and treating breast cancer |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972043A1 Human rantes mutants incapable of aggregate formation |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972037A2 $g(b)-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972035A1 Human tumor suppressor |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972031A1 Procollagen assembly |
| 01/19/2000 | EP0972030A2 70human secreted proteins |
| 01/19/2000 | EP0972029A1 Human secreted proteins |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
| 01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
| 01/19/2000 | EP0972022A2 Polynucleotides and polypeptides encoding receptors |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0972019A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971958A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971956A2 Synthetic saposin c-derived neurotrophic peptides |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971954A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971953A1 Vp22 proteins and uses thereof |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971949A1 Complexes and combinations of fetuin with therapeutic agents |
| 01/19/2000 | EP0971948A2 Inhibitors for urokinase receptor |
| 01/19/2000 | EP0971944A1 Anti-viral guanosine-rich tetrad forming oligonucleotides |
| 01/19/2000 | EP0971743A1 Stabilized medicaments containing cysteinyl derivatives |
| 01/19/2000 | EP0971742A1 Obesity protein formulations |
| 01/19/2000 | EP0971741A1 Use of avian antibodies |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0971732A1 New application for antithrombin iii |
| 01/19/2000 | EP0971731A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 01/19/2000 | EP0971730A2 Assay for ligands to tyrosine kinase receptors |
| 01/19/2000 | EP0971729A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin |
| 01/19/2000 | EP0971728A1 Use of interleukin-15 |
| 01/19/2000 | EP0971727A1 Production process for intravenous immune serum globulin and resultant product |
| 01/19/2000 | EP0971726A1 Peptides for inhibiting retroviruses |
| 01/19/2000 | EP0971725A1 Methods for treatment of scar tissue |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0971723A1 Compositions and methods for inhibiting cellular proliferation |
| 01/19/2000 | EP0971703A1 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 01/19/2000 | EP0971698A1 Aerosolized hydrophobic drug |
| 01/19/2000 | EP0971686A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein |
| 01/19/2000 | EP0966227A4 Composition containing a radioactive component for treatment of vessel wall |
| 01/19/2000 | EP0897392A4 Isolation and use of sh3 binding peptides |
| 01/19/2000 | EP0814826A4 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 01/19/2000 | EP0772631A4 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0713395A4 Polymeric carriers for non-covalent drug conjugation |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | CN1242049A Multi-functional chimeric hematopoletic receptor agonists |
| 01/19/2000 | CN1242046A Mammalian cytokine related to IL10 |
| 01/19/2000 | CN1242045A Immunotherapy and improved vaccines |
| 01/19/2000 | CN1242044A Stable expression of triple helical proteins |
| 01/19/2000 | CN1242043A Receptor ligand VEGF-C |
| 01/19/2000 | CN1242014A Novel heterocyclic amide compounds and medicinal uses thereof |
| 01/19/2000 | CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors |
| 01/19/2000 | CN1241945A Isolated peptides which complex with HLA-Cw*16 molecules, and ues thereof |
| 01/19/2000 | CN1241634A Phytase formulation |
| 01/19/2000 | CN1241429A Medicine for preventing chronic lead poisoning |
| 01/19/2000 | CN1048523C Method for preparing viral protein generated from hepatitisvirokine |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015893 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 01/18/2000 | US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents |
| 01/18/2000 | US6015890 EmbCAB operon of mycobacteria and mutants thereof |
| 01/18/2000 | US6015889 Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 01/18/2000 | US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015882 Amino acid sequence of antigen gp900 detected at the surface of cryptosporidium sporozoites or merozoites; for antiprotozoa agents |
| 01/18/2000 | US6015879 Compounds for treatment of nervous system disorders including alzheimer's disease, cognition defects, down's syndrome, parkinson's disease, cerebral hemorrhage with amyloidosis, dementia pugilistica, and head trauma |
| 01/18/2000 | US6015878 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015794 Trans-splicing ribozymes |
| 01/18/2000 | US6015791 Serine protease inhibitors-cycloheptane derivatives |
| 01/18/2000 | US6015790 Methods and compositions for treating rheumatoid arthritis |
| 01/18/2000 | US6015789 Combined use of GnRH agonist and antagonist |
| 01/18/2000 | US6015788 Diagnosis and treatment of alzheimer's disease and various autoimmune disorders such as sle, systemic lupus erythematosus |